Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates


Myasthenia gravis (first report with peginterferon-α-2b): case report

    • 6 Accesses

    This is a preview of subscription content, log in to check access.


    1. 1.

      Bektas M, Bektas H, Goren D, Altan M, Cetinkaya H.Development of myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin. Digestion 75: 208-209, No. 4, 2007 - Turkey

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Peginterferon-α-2b/ribavirin. React. Wkly. 1186, 31 (2008). https://doi.org/10.2165/00128415-200811860-00099

    Download citation


    • Public Health
    • Hepatitis
    • Interferon
    • Patient Outcome
    • Congenital Anomaly